Roche (RHHBY)(RHHBF)(RHHVF) said its experimental eye drug vamikibart helped patients maintain improvements in vision for a full year in two late-stage clinical trials, potentially offering an ...
Merck ( MRK) said its experimental eye drug remigromig improved vision in patients with a diabetes-related eye disease, ...
Three people have received an innovative treatment designed to rejuvenate vision cells. In a presentation at the annual ...
MedPage Today on MSN
Genetically engineered treatment for blindness shows early promise in small study
Seven of 10 patients with advanced retinitis pigmentosa had improved light sensitivity ...
Five-year data show pegcetacoplan slows geographic atrophy, with earlier treatment preserving more retinal tissue than delayed treatment.
Six of ten patients in a small trial improved by two or more steps on a severity scale after one treatment, though the data ...
Kodiak's eye drug Zenkuda edges towards approval after another successful Phase III trial in wet AMD adds to other successful ...
SYCUME® Significantly Improved Proptosis (Response Rate 60.4% / LS Mean Change from Baseline -1.88 mm) with Favorable Safety Profile in Participants with Inactive Thyroid Eye ...
Five years after a landmark result in one patient, the first treated cohort shows that optogenetic vision restoration works beyond a single ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced progress in the development of BL1243 (tonabersat ...
By Nancy Lapid Oct 9 (Reuters) - It's Nobel Prize season and today we feature promising early results of a novel technique for treating blindness that made Nobel laureates of three scientists this ...
Administering Keytruda via subcutaneous injection instead of an intravenous drip.In September 2026, such a drug was approved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results